Kaisai Biotech: Audit Report issued by Tianjian Certified Public Accountants (Special General Partnership) on the Company\'s 2024 Annual Report
Kaisai Biotech: 2024 Independent Director Debriefing Report (Wu Xiangyang)
Cathay Biotech: China Merchants Securities Co., Ltd.\'s inspection opinions on the storage and use of funds raised by Shanghai Kaisai Biotechnology Co., Ltd. in 2024
Cathay Biotech: Non-operating capital occupation and other related capital transactions in 2024
Kaiser Biotech: 2024 Annual Report Summary
Cathay Biotech: 2024 Board Audit Committee Performance Report
Kaisai Biotech: Report on the Audit Committee\'s performance of supervisory duties on accounting firms
Kaisai Biotech: 2025 Action Plan to Improve Quality, Increase Efficiency, and Reward
Kaisai Biotech: 2024 Independent Director Debriefing Report (Lu Faqin)
Kaisai Biotech: Tianjian Certified Public Accountants (Special General Partnership) Audit Report on the Company\'s Internal Control
Kaisai Biotech: Performance Evaluation Report on Tianjian Certified Public Accountants (Special General Partnership)
Kaiser Biotech: 2024 Annual Report
Cathay Biotech: Audit report issued by an accounting firm on the storage and use of funds raised by the company in 2024
Cathay Biotech: CITIC Securities Co., Ltd.\'s verification opinion on Shanghai Kaisai Biotechnology Co., Ltd. permanently replenish working capital from savings raised from some fund-raising projects
Cathay Biotech: 2024 Internal Control Evaluation Report
Kaiser Biotech: 2024 Social Responsibility Report
Kaisai Biotech: 2024 Independent Director Debriefing Report (Zhang Bing)
Kaisai Biotech: Special Report on the Storage and Actual Use of Funds Raised in 2024
Cathay Biotech: CITIC Securities Co., Ltd.\'s inspection opinions on the storage and use of funds raised by Shanghai Kaisai Biotechnology Co., Ltd. in 2024
Kaisai Biotech: Announcement of Resolutions of the 24th Meeting of the 2nd Board of Supervisors